BRIEF published on 12/01/2025 at 15:57, 9 months 20 days ago Vanguard Group Discloses Stake in JTC plc Securities Takeover Code Stake Vanguard JTC Plc
BRIEF published on 12/01/2025 at 15:56, 9 months 20 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 12/01/2025 at 15:55, 9 months 20 days ago The Vanguard Group Discloses Position in Greencore Group The Vanguard Group Takeover Code Public Disclosure Securities Position Greencore Group
PRESS RELEASE published on 12/01/2025 at 15:54, 9 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.79% stake in Qualcomm Incorporated as of 28 Nov 2025. They also disclose dealings involving stock purchases and sales Vanguard Group Financial Disclosure Stake Disclosure Stock Dealings Qualcomm
BRIEF published on 12/01/2025 at 15:53, 9 months 20 days ago The Vanguard Group Discloses Position in Spire Healthcare Group plc Form 8.3 Takeover Code Vanguard Group Spire Healthcare Shareholding Disclosure
PRESS RELEASE published on 12/01/2025 at 15:53, 9 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.49% interest in American Axle & Manufacturing Holdings, Inc. as of 28 Nov 2025. Additional dealings detailed in Form 8.3 Form 8.3 Financial Dealings The Vanguard Group Interest Disclosure American Axle & Manufacturing Holdings
BRIEF published on 12/01/2025 at 15:52, 9 months 20 days ago The Vanguard Group Discloses Stake in Alphawave IP Group Financial Position Takeover Code Vanguard Group Stake Disclosure Alphawave IP
PRESS RELEASE published on 12/01/2025 at 15:52, 9 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% stake in JTC plc through Form 8.3. Dealings include purchasing 7,566 securities at 12.75 GBP per unit Form 8.3 Securities Dealings Vanguard Group Stake Disclosure JTC Plc
PRESS RELEASE published on 12/01/2025 at 15:51, 9 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.73% ownership in Avadel Pharmaceuticals plc as of 28 November 2025 under Rule 8.3 of the Irish Takeover Panel Act Irish Takeover Panel The Vanguard Group Rule 8.3 Ownership Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 12/01/2025 at 15:51, 9 months 20 days ago The Vanguard Group's Stake in Dowlais Group plc: 8.3 Disclosure Equity Stake Takeover Code Securities Disclosure Vanguard Group Dowlais Group
Published on 09/21/2026 at 15:45, 5 hours 37 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 7 hours 2 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 7 hours 17 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 7 hours 22 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 7 hours 37 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 20:34, 47 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 18:00, 3 hours 22 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 3 hours 37 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 3 hours 37 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 4 hours 22 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 3 hours 3 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 3 hours 20 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 3 hours 36 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 14 hours 22 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
